XINDREL, created in 2005 (United States), from 585 sister brands and 17478 competing brands. The XINDREL brand is owned by ASTRAZENECA, a company listed in London. The International Securities Identification Number (ISIN) of ASTRAZENECA is GB0009895292. XINDREL belongs to the Drug Manufacturers business sector.